Photo of Xiu-Min Li

Xiu-Min Li

  • PROFESSOR Pediatrics, Allergy and Immunology
Print ProfilePrint Profile

Clinical Focus

Education

  • MD, Henan Medical University

Biography

    Xiu-Min Li, M.D., focuses her research on food allergy and allergic asthma. In the area of food allergy, she is investigating the immunopathogenic mechanisms underlying food allergy and novel therapies for these allergic diseases. She is involved in teaching sessions with the fellows and coordinates weekly immunology rounds, which include clinical case presentations, review of journal articles, and lectures from invited speakers. Her clinical research has included clinical trials in both asthma and allergic diseases. She has recently been involved in studying hypersensitivity and the potential of CpG oligodeoxynucleotide treatment for allergic asthma, also utilizing animal models. In addition, Dr. Li is exploring herbal medicines for the treatment of allergic asthma and food allergy.

    East-West Scientific Symposia on Allergy (April 13-18, 2010)

    Dr Li will be among a panel of  Western and Eastern medical scientists to host a symposia to exchange scientific progress on understanding food and environmental allergies in order to prevent and treat allergic disorders. For more information and to register, please download the agenda and registration form:

    Flyer

    Registration Page

     
    You may also register online (beginning on January 2, 2010).

     
    In the News

    Dr. Li and her work were recently profiled in The Daily News feature The Daily Check Up. View the PDF.

Research

Principal investigator: Xiu-Min Li, M.D., associate professor of pediatric allergy/immunology, Mount Sinai School of Medicine, New York, New York.

Dr. Li and her colleagues are studying a three-herb Chinese formula called ASHMI as a therapy for asthma. ASHMI, which was developed at Mount Sinai, is based on a formula that Dr. Li was familiar with from her practice of medicine in China. Dr. Li notes that there is not yet any effective therapy for persistent, severe asthma, nor any way to prevent it. Also, while conventional therapies can be helpful for many asthma patients, she says, corticosteroids (the cornerstone of treatment) often cause serious side effects and, if the medication is stopped, worsen the disease.

This CERC's three studies are looking at the mechanism of action of ASHMI in an animal model, finding out more about its active components, and investigating it in phase I and phase II clinical trials. So far, the team has found that ASHMI has broad therapeutic actions on multiple asthma-related mechanisms in an animal model, and that the effects are long lasting. They have almost completed their phase I study and are moving toward a proposed phase II clinical trial. "The beauty of a CERC," says Dr. Li, "is that we have three independent but highly interactive projects and experts from many fields. Studying and developing a first-generation botanical drug is a very big project."

Publications

Song Y, Dunkin D, Dahan S, Iuga A, Ceballos C, Hoffstadter-Thal K, Yang N, Benkov K, Mayer L, Li XM. Anti-inflammatory effects of the Chinese herbal formula FAHF-2 in experimental and human IBD. Inflammatory bowel diseases 2014 Jan; 20(1).

Srivastava KD, Dunkin D, Liu C, Yang N, Miller RL, Sampson HA, Li XM. Effect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2014 Apr; 112(4).

Yang N, Chung D, Liu C, Liang B, Li XM. Weight loss herbal intervention therapy (W-LHIT) a non-appetite suppressing natural product controls weight and lowers cholesterol and glucose levels in a murine model. BMC complementary and alternative medicine 2014 Jul; 14.

Ceballos C, Bao R, Dunkin D, Song Y, Li XM, Benkov K. Complementary and alternative medicine use at a single pediatric inflammatory bowel disease center. Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates Jul-Aug; 37(4).

Birmingham JM, Gillespie VL, Srivastava K, Li XM, Busse PJ. Influenza A infection enhances antigen-induced airway inflammation and hyperresponsiveness in young but not aged mice. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 2014 Sep; 44(9).

Zhou Z, Gong S, Li X, Yang Y, Guan R, Zhou S, Yao S, Xie Y, Ou Z, Zhao J, Liu Z. Expression of Helicobacter pylori urease B on the surface of Bacillus subtilis spores. Journal of medical microbiology 2014 Oct;.

Yang N, Wang J, Liu C, Song Y, Zhang S, Zi J, Zhan J, Masilamani M, Cox A, Nowak-Wegrzyn A, Sampson H, Li XM. Berberine and limonin suppress IgE production by human B cells and peripheral blood mononuclear cells from food-allergic patients. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2014 Nov; 113(5).

Song Y, Liu C, Hui Y, Srivastava K, Zhou Z, Chen J, Miller RL, Finkelman FD, Li XM. Maternal allergy increases susceptibility to offspring allergy in association with TH2-biased epigenetic alterations in a mouse model of peanut allergy. The Journal of allergy and clinical immunology 2014 Dec; 134(6).

Lisann L, Song Y, Wang J, Ehrlich P, Maitland A, Li XM. Successful prevention of extremely frequent and severe food anaphylaxis in three children by combined traditional Chinese medicine therapy. Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2014 Dec; 10(1).

López-Expósito I, Srivastava KD, Birmingham N, Castillo A, Miller RL, Li XM. Maternal Antiasthma Simplified Herbal Medicine Intervention therapy prevents airway inflammation and modulates pulmonary innate immune responses in young offspring mice. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2015 Jan; 114(1).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Li during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)

  • Herbal Springs LLC

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.

Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.

Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central

Address

Annenberg Building Floor 17th Room 30
1468 Madison Avenue
New York, NY 10029

Tel: 212-241-5548